University of Minnesota
1,539
230
293
964
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.7%
195 terminated/withdrawn out of 1539 trials
83.2%
-3.3% vs industry average
9%
135 trials in Phase 3/4
38%
366 of 964 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1539)
Myofunctional Therapy for Obstructive Sleep Apnea
Role: lead
Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia
Role: lead
Cognitive Strategies in Early Psychosis 2
Role: lead
TRE in Type 2 Diabetes (See Food Study 3)
Role: lead
Community-based Communication for Blood Donation in Ghana
Role: lead
B-PaLMZ for TB Meningitis
Role: lead
MRI Technical Development and Applications in Kidney Disease
Role: lead
A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities
Role: lead
The Implementation of a Post-operative Communication App to Improve Pain Control and Opioid Use
Role: lead
Intestinal Microbiome Transplant in ALS
Role: collaborator
Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)
Role: lead
CBIT+TMS R33 Phase
Role: lead
Pathways 2 Success
Role: lead
Genetic Modifiers of Cystic Fibrosis Related Diabetes
Role: collaborator
Improving Barriers to Care Access for Children With Autism and Related Needs Via Telehealth for Evaluation, Care Navigating, and Caregiver Coaching
Role: lead
Microbiome-targeted Diet Therapy in Ulcerative Colitis
Role: lead
A Prospective Observational Study of TPIAT
Role: lead
Food at Home Study
Role: lead
Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya
Role: lead
Intracranial Stimulation Mapping In Epilepsy
Role: lead